Collagen degradation in glaucoma: Will it gain a therapeutic value?

Current Opinion in Ophthalmology

Volumn 11, Issue 2, 2000, Pages 90-93

  La Rosa, Francis A ^a   Lee, David A ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; MATRIX METALLOPROTEINASE; PROSTAGLANDIN DERIVATIVE; STEROID;

AQUEOUS HUMOR OUTFLOW; ARGON LASER; COLLAGEN DEGRADATION; DRUG MECHANISM; EXTRACELLULAR MATRIX; HUMAN; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; REVIEW; TRABECULOPLASTY;

ANIMALS; COLLAGEN; DRUG THERAPY, COMBINATION; EXTRACELLULAR MATRIX; GLAUCOMA, OPEN-ANGLE; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; MATRIX METALLOPROTEINASES; PROSTAGLANDINS, SYNTHETIC;

EID: 0034066324     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200004000-00004     Document Type: Review

References (21)

1. Yue BY: The extracellular matrix and its modulation in the trabecular meshwork. Surv Ophthalmol 1996, 40:379-390.
2. Yang JL, Neufeld AH, Zorn MB, Hernandez MR: Collagen type I mRNA levels in cultured human lamina cribrosa cells: effects of elevated hydrostatic pressure. Exp Eye Res 1993, 56:567-574.
3. Sawaguchi S, Yue BYJT, Fukuchi T, Abe H, Suda K, Kaiya T, et al.: Collagen fibrillar network in the optic nerve head of normal monkey eyes and monkey eyes with laser-induced glaucoma-a scanning electron microscopic study. Curr Eye Res 1999, 18:143-149.
4. Alexander CM, Werb Z: Extracellular matrix degradation. In Cell Biology of Extracellular Matrix, ed. 2. Hay ED, ed. New York: Plenum; 1991:255-302.
5. Barany EH: The effect of different kinds of hyaluronidase on the resistance to flow through the angle of the anterior chamber. Acta Ophthalmol 1956, 33: 397-403.
6. Clark AF: New discoveries on the roles of matrix metalloproteinases in ocular cell biology and pathology. Invest Ophthalmol Vis Sci 1998, 39:2514-2516.
7. Huang SH, Adamis AP, Wiederschain DG, Shima DT, Shing Y, Moses MA: Matrix metalloproteinases and their inhibitors in aqueous humor. Exp Eye Res 1996, 62:481-490.
8. Alexander JP, Samples JR, Van Buskirk EM, Acott TS: Expression of matrix metalloproteinases and inhibitors by human trabecular meshwork. Invest Ophthalmol Vis Sci 1991, 32:172-180.
9. Bradley JMB, Vranka J, Colvis CM, Conger DM, Alexander P, Fisk AS et al.: Effect of matrix metalloproteinase activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci 1998, 39:2649-2658.
10. Samples JR, Alexander JP, Acott TS: Regulation of the levels of human trabecular matrix metalloproteinases and inhibitors by interleukin-1 and dexamethasone. Invest Ophthalmol Vis Sci 1993, 34:3386-3395.
11. Parshley DE, Bradley JM, Samples JR, Van Buskirk EM, Acott TS: Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork. Curr Eye Res 1995, 14:537-544.
12. Parshley DE, Bradley JM, Fisk A, Hadaegh A, Samples JR, Van Buskirk EM, et al.: Laser trabeculoplasty induces stromelysin expression by trabecular juxtacanalicular cells. Invest Ophthalmol Vis Sci 1996, 37:795-804.
13. Lindsey JD, Kashiwagi K, Boyle D, Kashiwagi F, Firestein GS, Weinreb RN: Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells. Curr Eye Res 1996, 15:869-875.
14. Weinreb RN, Kashiwagi K, Kashiwagi F, Tsukahara S, Lindsey JD: Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci 1997, 38:2772-2780.
15. Gaton DD, Sagara T, Lindsey JD, Weinreb RN: Matrix metalloproteinase-1 localization in the normal human uveoscleral outflow pathway. Invest Ophthalmol Vis Sci 1999, 40:363-369.
16. Sagara T, Gaton DD, Lindsey JD, Gabelt BT, Kaufman PL, Weinreb RN: Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway. Arch Ophthalmol 1999, 117:794-801.
17. Avila GG, Ginebra M, Hayakawa T, Ortega FN, Teran L, Selman M: Collagen metabolism in human aqueous humor from primary open-angle glaucoma. Arch Ophthalmol 1995, 113:1319-1323.
18. Snyder RW, Stamer WD, Kramer TR, Seftor RE: Corticosteroid treatment and trabecular meshwork proteinases in cell and organ culture supernatants. Exp Eye Res 1993, 57:461-468.
19. Kawashima Y, Saika S, Yamanaka O, Okada Y, Ohkawa K, Ohnishi Y: Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human subconjunctival tissues. Curr Eye Res 1998, 17:445-451.
20. Dan JA, Yaron A: Focal scleral permeability enhanced by collagenase digestion. Ophthalmology 1994, 101:461-472.
21. Loftfield K, Ball SF: Filtering bleb encapsulation increased by steroid injection. Ophthalmic Surg 1990, 4:282-287.